Imagine being told you can only receive one type of medication, regardless of what your doctor thinks is best. That’s the reality for some patients under a controversial policy defended by a third-party healthcare administrator, MiCare. But here's where it gets controversial: while MiCare claims it respects doctors' clinical autonomy, it also insists that banks—not medical professionals—ultimately decide the scope and limits of medical treatments. This has sparked a heated debate among healthcare providers and patient advocates.
On November 14, 2025, MiCare issued a statement clarifying its role in administering medical claims for banks. According to the company, its responsibility is to evaluate, process, and manage claims within the boundaries set by banks, in compliance with legal and contractual obligations. In simpler terms, MiCare acts as the middleman, ensuring that medical treatments and medications align with what banks are willing to cover. If a treatment or medication falls outside these parameters, the cost falls on the employee—not the bank or the insurer.
MiCare emphasizes that it fully supports doctors' independence in deciding the best treatment for their patients. However, a private general practitioner, speaking anonymously, pointed out a critical issue: clinics are caught in the middle, forced to adhere to TPA policies or risk losing their panel status. This means that even if a doctor believes a branded medication is necessary, they might be pressured to prescribe a generic alternative to comply with the bank’s policy.
And this is the part most people miss: the Malaysian Medical Association (MMA) has openly criticized such generic-only mandates, arguing that they compromise patient care and undermine doctors' professional ethics. The MMA highlights that the Private Healthcare Facilities and Services Act 1998 and the health ministry’s guidelines explicitly forbid TPAs from interfering in clinical decisions. So, who should have the final say—banks, TPAs, or doctors?
This debate raises a thought-provoking question: Are we prioritizing cost savings over patient well-being? While generic medications are often effective and affordable, they aren’t always the best option for every patient. Should financial constraints dictate medical decisions, or should doctors have the freedom to prescribe what they believe is best? Let us know your thoughts in the comments—this is a conversation that deserves your voice.
